Atara Biotherapeutics (ATRA) Current Leases (2019 - 2026)
Atara Biotherapeutics' (ATRA) quarterly Current Leases came in at $1.0 million in Q1 2026, down 5.23% YoY from $1.1 million in Q1 2025, and down 1.36% on a QoQ basis from $1.0 million in Q4 2025.
Atara Biotherapeutics (ATRA) Current Leases (2019 - 2026) Analysis & Trends
Atara Biotherapeutics (ATRA) has 8 years of Current Leases data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Current Leases fell 5.23% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 5.23% YoY) and the FY2025 annual result came in at $1.0 million, down 92.02% from the prior year.
- Current Leases declined to $1.0 million in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $13.1 million in Q1 2024 to a low of $832000.0 in Q1 2023.
- A 5-year average of $5.6 million and a median of $1.1 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases surged 1472.96% — and 2025, when it slumped 92.02%.
- Tracing ATRA's Current Leases over 5 years: stood at $834000.0 in 2022, then gained by 9.71% to $915000.0 in 2023, then jumped by 1307.54% to $12.9 million in 2024, then tumbled by 92.02% to $1.0 million in 2025, then fell by 1.36% to $1.0 million in 2026.
- The last three Current Leases figures came in at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $2.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | - |
| 10 | Atara Biotherapeutics | 144.47 Mn | 127.92 Mn | 439,000.00 | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 12.88 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 13.02 Mn |
| Mar 31, 2024 | 13.09 Mn |
| Dec 31, 2023 | 915,000.00 |
| Sep 30, 2023 | 12.41 Mn |
| Jun 30, 2023 | 12.10 Mn |
| Mar 31, 2023 | 832,000.00 |
| Dec 31, 2022 | 834,000.00 |
| Dec 31, 2021 | 2.58 Mn |
| Dec 31, 2020 | 1.73 Mn |
| Dec 31, 2019 | 1.31 Mn |